Vext Science, Inc. ("VEXT" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it has received approval from the Arizona Department of Health Services to begin selling recreational cannabis.
Eric Offenberger, CEO of VEXT, commented, "Arizona is already one of the largest medical cannabis markets in the U.S. and its transition into a recreational market is a significant step forward for the cannabis industry broadly, for customers and patients in the state, and for VEXT. In preparation for today, we have made the necessary investments throughout the supply chain - from cultivation, to manufacturing and retail - to ensure our retail locations can handle a significant and sustained volume increase, and that we can keep up with demand for VapenTM product from other dispensaries in the state. With one of the state's top selling cannabis brands, two strategically located dispensaries in Phoenix and the upstream infrastructure to handle a significant increase in volume, this is a very exciting time for VEXT."